In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A).
MDL 62,879 (GE2270 A) is a new peptide antibiotic that inhibits protein synthesis through an interaction with elongation factor Tu. MDL 62,879 was very active against gram-positive clinical isolates, particularly staphylococci and enterococci, for which MICs for 90% of isolates were < or = 0.13 micr...
Enregistré dans:
| Publié dans: | Antimicrob Agents Chemother |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology (ASM)
1993
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187747/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8494369/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.4.741 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|